Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Hasan

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Acta Neuropathologica Communications|May 2, 2024
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, et al.
Cancers|January 10, 2026
Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World DataAnn-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor TreatmentStefan Diem, Mirjam Fässler, David Bomze, et al.
Archives of Internal Medicine|November 11, 2009
Diagnostic error in medicine: analysis of 583 physician-reported errorsGordon D Schiff, Omar Hasan, Seijeoung Kim, et al.
Journal of Neurotrauma|May 1, 2014
Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recoveryBrian J Kelley, Noam Y Harel, Chang-Yeon Kim, et al.
Annals of Neurology|December 14, 2011
Recovery from chronic spinal cord contusion after Nogo receptor interventionXingxing Wang, Philip Duffy, Aaron W McGee, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2021
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patientsMette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, et al.
Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Pseudorabies virus hijacks DDX3X, initiating an addictive "mad itch" and immune suppression, to facilitate viral spreadShane J F Cronin, Miguel A Tejada, Ren Song, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Acta Neuropathologica Communications|May 2, 2024
Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19Nathalie A Lengacher, Julianna J Tomlinson, Ann-Kristin Jochum, et al.
Cancers|January 10, 2026
Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World DataAnn-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 16, 2019
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor TreatmentStefan Diem, Mirjam Fässler, David Bomze, et al.
Archives of Internal Medicine|November 11, 2009
Diagnostic error in medicine: analysis of 583 physician-reported errorsGordon D Schiff, Omar Hasan, Seijeoung Kim, et al.
Journal of Neurotrauma|May 1, 2014
Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recoveryBrian J Kelley, Noam Y Harel, Chang-Yeon Kim, et al.
Annals of Neurology|December 14, 2011
Recovery from chronic spinal cord contusion after Nogo receptor interventionXingxing Wang, Philip Duffy, Aaron W McGee, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2021
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patientsMette-Triin Purde, Rebekka Niederer, Nikolaus B Wagner, et al.
Journal of the American Academy of Dermatology|August 27, 2019
BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitorsOmar Hasan Ali, David Bomze, Sandra S Ring, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Pseudorabies virus hijacks DDX3X, initiating an addictive "mad itch" and immune suppression, to facilitate viral spreadShane J F Cronin, Miguel A Tejada, Ren Song, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Pageof 10